ArticleOncotarget2017

Physiological characterization of a novel PPAR pan agonist, 2-(4-(5,6-methylenedioxybenzo[d]thiazol-2-yl)-2-methylphenoxy)-2-methylpropanoic acid (MHY2013).

Hye Jin An et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.